Year-End Report
CLS STRATEGIES (FORMERLY CHLOPAK, LEONARD, SCHECHTER AND ASSOCIATES, INC.) for INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP)
Income
$20,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General issue is the FDA regulations of compounding pharamacy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSHUA WENDEROFF | N/A |
Pharmacy PHA
General issue is the FDA regulations of compounding pharamacy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOSHUA WENDEROFF | N/A |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.